Best Buy (BBY) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Achieved positive comparable sales in Q4 FY25, first since Q3 FY22, reflecting operational discipline and strategic investments in digital and in-store experiences.
My Best Buy membership program reached nearly 8 million paid members, fueling data-driven initiatives like Best Buy Ads.
Returned $1.3 billion to shareholders via repurchases and dividends; increased quarterly dividend for the 12th consecutive year.
Employee engagement and retention reached record highs, with the lowest turnover in six years.
Voting matters and shareholder proposals
Shareholders will vote on: election of 11 directors, ratification of Deloitte & Touche LLP as auditor, advisory say-on-pay, and approval of Amendment No. 1 to the 2020 Omnibus Incentive Plan.
Four shareholder proposals: right to act by written consent, request to cease CEI participation, report on LGBTQIA+ inclusion, and publish a climate transition plan; Board recommends voting against all four.
Board recommends voting for all management proposals.
Board of directors and corporate governance
Board consists of 11 members, 10 of whom are independent; diverse in gender and ethnicity.
Independent Chair; all committees are independent.
Annual director elections, majority voting, no cumulative voting, no poison pill, and proxy access by-laws.
Robust annual board, director, and CEO evaluation processes; director retirement policy at age 72.
Latest events from Best Buy
- AI-driven innovation, Marketplace growth, and resilient supply chain strategies fuel future success.BBY
UBS Global Consumer and Retail Conference12 Mar 2026 - Q4 profit rose on stable sales; FY27 outlook sees margin gains and strong capital returns.BBY
Q4 20263 Mar 2026 - Omnichannel strategy, innovation, and AI are driving growth amid evolving consumer trends.BBY
Oppenheimer's 24th Annual Virtual Consumer Growth and E-Commerce Conference1 Feb 2026 - EPS up, margins improved, and FY25 guidance raised despite 3.1% revenue decline.BBY
Q2 202523 Jan 2026 - Q3 sales declined but gross margin and capital returns improved amid cautious FY25 guidance.BBY
Q3 202512 Jan 2026 - Q4 beat expectations; FY26 outlook steady, with tariffs and shareholder returns in focus.BBY
Q4 20257 Jan 2026 - Shareholders approved all board recommendations, with key topics including compensation, buybacks, and risk.BBY
AGM 20256 Jan 2026 - Adjusted EPS up 11% to $1.40, but GAAP EPS fell on health impairments and restructuring.BBY
Q3 20265 Dec 2025 - Definitive proxy statement filed for shareholder action under Section 14(a).BBY
Proxy Filing1 Dec 2025